Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Other Operating Expenses (2017 - 2026)

Updated

Grace Therapeutics (GRCE) recorded Other Operating Expenses of $885,000 in fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$192,000 a year earlier and up 719.4% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Other Operating Expenses (2017 - 2026) Analysis & Trends

On a TTM basis, Grace Therapeutics' Other Operating Expenses came in at $408,000 as of Sep 30, 2026, down 82.1% year-over-year; for FY2026 (ended Mar 31, 2026), it was -$624,000.

  • Across earlier fiscal years, Other Operating Expenses came in at $6.67 million in FY2025 (+151.3%), $2.66 million in FY2024 (-73.4%), $9.97 million in FY2023 (+79.4%) and $5.56 million in FY2022 (+35.7%).
  • The fiscal Q2 2027 figure is the highest quarterly Other Operating Expenses since fiscal Q3 2025.
  • On a year-over-year basis, Other Operating Expenses rose in 1 of the last four quarters, with an average decline of 42.3%.
  • Peak year-over-year performance for Other Operating Expenses in the last five years was growth of 463.2% in fiscal Q4 2022, against a decline of 92.7% in fiscal Q1 2026 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $108,000 (Q1 2027), -$296,000 (Q4 2026) and -$289,000 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 384,000.00
Mar 31, 2026 534,000.00
Dec 31, 2025 595,000.00
Sep 30, 2025 380,000.00
Jun 30, 2025 552,000.00
Mar 31, 2025 398,000.00
Dec 31, 2024 349,000.00
Sep 30, 2024 267,000.00
Jun 30, 2024 224,000.00
Sep 30, 2022 4,000.00
Jun 30, 2022 6,000.00
Jun 30, 2017 -1,487.43
API Access

Grace Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=GRCE&period=max&api_key=YOUR_API_KEY